Greenwich LifeSciences (GLSI)
(Real Time Quote from BATS)
$14.43 USD
+0.26 (1.84%)
Updated Sep 19, 2024 09:56 AM ET
4-Sell of 5 4
D Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
GLSI 14.43 +0.26(1.84%)
Will GLSI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GLSI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GLSI
After Golden Cross, Greenwich LifeSciences, Inc. (GLSI)'s Technical Outlook is Bright
GLSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for GLSI
Greenwich LifeSciences price target raised by $2 at H.C. Wainwright, here's why
GLSI Stock Earnings: Greenwich LifeSciences Reported Results for Q2 2024
Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
Greenwich LifeSciences provides update on FLAMINGO-01 trial
Greenwich LifeSciences: Trying To Move A Needle That Doesn't Like To Budge